A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...
A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.
UW Health's Dr. Bill Hartman discusses ways to slow down aging, a study that says high school student's aren't getting enough ...
1d
Axios Vitals on MSNOregon researchers develop new test for pancreatic cancerResearchers at Oregon Health & Science University have developed a new blood test that they say is able to detect pancreatic ...
EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...
Pancreatic cancer is fueled by connections to the nervous system. This is reported by scientists from the German Cancer ...
The tool predicts which of two standard front-line chemotherapy options a patient with advanced pancreatic cancer is likely to benefit from.
The company’s CLIA-certified lab in Irvine, California, is licensed by the California Department of Public Health and will perform the test.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results